Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnosing and predicting refractory epilepsy.

M J Brodie1

  • 1Epilepsy Unit, Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, UK. martin.j.brodie@clinmed.gla.ac.uk

Acta Neurologica Scandinavica. Supplementum
|October 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perampanel for focal epilepsy: insights from early clinical experience.

Acta neurologica Scandinavica·2015
Same author

Zonisamide: its pharmacology, efficacy and safety in clinical trials.

Acta neurologica Scandinavica. Supplementum·2012
Same author

Patterns of treatment response in newly diagnosed epilepsy.

Neurology·2012
Same author

Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.

Acta neurologica Scandinavica·2011
Same author

Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Biochemical pharmacology·2010
Same author

Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy.

Neurology·2010

Over 30% of epilepsy patients do not achieve remission with antiepileptic drugs (AEDs). Early identification of refractory epilepsy is crucial for timely specialist referral and optimized treatment strategies, including combination therapy.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Epilepsy affects millions globally, with a significant portion unresponsive to initial antiepileptic drug (AED) therapy.
  • Refractory epilepsy leads to severe disability, reduced quality of life, and increased mortality risk.
  • Current treatment paradigms often involve a trial-and-error approach for AED selection.

Purpose of the Study:

  • To highlight the unmet need for early identification of patients with refractory epilepsy.
  • To discuss factors associated with poor response to AEDs.
  • To emphasize the importance of timely referral for comprehensive epilepsy management.

Main Methods:

  • Review of recent studies identifying predictors of refractory epilepsy.
  • Analysis of diagnostic and therapeutic pathways for epilepsy management.

Related Experiment Videos

  • Discussion of treatment strategies for non-responsive epilepsy.

    • Main Results:

    • Over 30% of epilepsy patients fail to achieve remission with AEDs.
    • Factors like symptomatic epilepsy, early seizure burden, family history, and psychiatric comorbidities predict poor drug response.
    • Failure with first 1-2 AED monotherapies suggests potential for refractory epilepsy.

    Conclusions:

    • Early identification of refractory epilepsy is critical for prompt specialist referral.
    • Optimized AED therapy, including combination treatments, is essential for managing refractory cases.
    • Surgical assessment and advanced management strategies can improve outcomes for non-responsive epilepsy patients.